Trial Profile
A prospective, observational, multicenter study investigating the treatment adherence of Rheumatoid-arthritis patients switching from oral to injectable Methotrexate or between two different Methotrexate prefilled syringes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Nov 2018
Price :
$35
*
At a glance
- Drugs Methotrexate (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms APRiM
- 26 Nov 2018 New trial record
- 24 Oct 2018 Results presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting